These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28389200)

  • 1. Rituximab therapy in necrotizing autoimmune myopathy associated with anti-SRP antibody: A clinical case review.
    Nóvoa Medina FJ; Gutiérrez Martínez J; González González Y; Romero Díaz B; Machín García S; Rosas Romero A
    Reumatol Clin (Engl Ed); 2018; 14(6):379-381. PubMed ID: 28389200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
    Valiyil R; Casciola-Rosen L; Hong G; Mammen A; Christopher-Stine L
    Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy reversed myopathy but not cardiomyopathy in a necrotizing autoimmune myopathy patient with positive anti-SRP and MDA-5 autoantibodies.
    Ma X; Xu L; Li Y; Bu B
    BMC Cardiovasc Disord; 2021 Feb; 21(1):88. PubMed ID: 33579193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-SRP-positive necrotising myopathy concurrent with breast malignancy.
    Dandasena T; Ingle V; Singhai A; Saigal S
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38081733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
    Cui BB; Tian YR; Ma XY; Yin G; Xie Q
    Front Immunol; 2021; 12():777502. PubMed ID: 34925350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
    Pinal-Fernandez I; Parks C; Werner JL; Albayda J; Paik J; Danoff SK; Casciola-Rosen L; Christopher-Stine L; Mammen AL
    Arthritis Care Res (Hoboken); 2017 Feb; 69(2):263-270. PubMed ID: 27111848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients.
    Suzuki S; Nishikawa A; Kuwana M; Nishimura H; Watanabe Y; Nakahara J; Hayashi YK; Suzuki N; Nishino I
    Orphanet J Rare Dis; 2015 May; 10():61. PubMed ID: 25963141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of anti-Jo1 and anti-signal recognition particle antibodies in a polymyositis patient.
    Melguizo Madrid E; Fernández Riejos P; Toyos Sáenz de Miera FJ; Fernández Pérez B; González Rodríguez C
    Reumatol Clin (Engl Ed); 2019; 15(6):e111-e113. PubMed ID: 29396013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid Arthritis Associated With Anti-Signal Recognition Particle Immune-Mediated Necrotizing Myopathy: A Case Report.
    Belkhribchia MR; Lobrinus JA; Semlil L; Chauveau N; Ajrinija A; Egervari K; Ennhaili ZE
    J Investig Med High Impact Case Rep; 2024; 12():23247096241231646. PubMed ID: 38353222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion.
    Whelan BR; Isenberg DA
    Rheumatology (Oxford); 2009 May; 48(5):594-5. PubMed ID: 19254917
    [No Abstract]   [Full Text] [Related]  

  • 11. Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody.
    De Souza FHC; Miossi R; Shinjo SK
    Clin Exp Rheumatol; 2017; 35(5):766-771. PubMed ID: 28281460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
    Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
    Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired necrotizing myopathies.
    Allenbach Y; Benveniste O
    Curr Opin Neurol; 2013 Oct; 26(5):554-60. PubMed ID: 23995277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing Myopathy.
    Landon-Cardinal O; Allenbach Y; Soulages A; Rigolet A; Hervier B; Champtiaux N; Monzani Q; Solé G; Benveniste O
    J Rheumatol; 2019 Jun; 46(6):623-627. PubMed ID: 30554155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and outcomes in necrotising autoimmune myopathy: An Australian perspective.
    Ashton C; Junckerstorff R; Bundell C; Hollingsworth P; Needham M
    Neuromuscul Disord; 2016 Nov; 26(11):734-740. PubMed ID: 27665513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
    Basharat P; Christopher-Stine L
    Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrotizing autoimmune myopathy.
    Liang C; Needham M
    Curr Opin Rheumatol; 2011 Nov; 23(6):612-9. PubMed ID: 21885975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.